Identification of a Novel Gammaretrovirus in Prostate Tumors of Patients Homozygous for R462Q RNASEL Variant

Abstract

Ribonuclease L (RNase L) is an important effector of the innate antiviral response. Mutations or variants that impair function of RNase L, particularly R462Q, have been proposed as susceptibility factors for prostate cancer. Given the role of this gene in viral defense, we sought to explore the possibility that a viral infection might contribute to prostate cancer in individuals harboring the R462Q variant. A viral detection DNA microarray composed of oligonucleotides corresponding to the most conserved sequences of all known viruses identified the presence of gammaretroviral sequences in cDNA samples from seven of 11 R462Q-homozygous (QQ) cases, and in one of eight heterozygous (RQ) and homozygous wild-type (RR) cases. An expanded survey of 86 tumors by specific RT-PCR detected the virus in eight of 20 QQ cases (40%), compared with only one sample (1.5%) among 66 RQ and RR cases. The full-length viral genome was cloned and sequenced independently from three positive QQ cases. The virus, named XMRV, is closely related to xenotropic murine leukemia viruses (MuLVs), but its sequence is clearly distinct from all known members of this group. Comparison of gag and pol sequences from different tumor isolates suggested infection with the same virus in all cases, yet sequence variation was consistent with the infections being independently acquired. Analysis of prostate tissues from XMRV-positive cases by in situ hybridization and immunohistochemistry showed that XMRV nucleic acid and protein can be detected in about 1% of stromal cells, predominantly fibroblasts and hematopoietic elements in regions adjacent to the carcinoma. These data provide to our knowledge the first demonstration that xenotropic MuLV-related viruses can produce an authentic human infection, and strongly implicate RNase L activity in the prevention or clearance of infection in vivo. These findings also raise questions about the possible relationship between exogenous infection and cancer development in genetically susceptible individuals.

Full text

We don’t show the text of a retracted or withdrawn paper. The record stays, so citations to it can be checked.

Cited by papers we hold 15

• Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) · 2018
  No notice
• Virus Identification in Unknown Tropical Febrile Illness Cases Using Deep Sequencing · 2012
  No notice
• Xenotropic murine leukemia virus-related virus is not associated with chronic fatigue syndrome in patients from different areas of the us in the 1990s · 2011
  Not checked
• A case-cohort study of human herpesvirus 8 seropositivity and incident prostate cancer in Tobago · 2011
  Not checked
• Temporal Analysis of the Honey Bee Microbiome Reveals Four Novel Viruses and Seasonal Prevalence of Known Viruses, Nosema, and Crithidia · 2011
  No notice
• Cross-Species Transmission of a Novel Adenovirus Associated with a Fulminant Pneumonia Outbreak in a New World Monkey Colony · 2011
  Corrected
• Raltegravir is a potent inhibitor of XMRV, a virus implicated in prostate cancer and chronic fatigue syndrome. · 2010
  Not checked
• Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome · 2010
  No notice
• A Metagenomic Analysis of Pandemic Influenza A (2009 H1N1) Infection in Patients from North America · 2010
  No notice
• Failure to Detect the Novel Retrovirus XMRV in Chronic Fatigue Syndrome · 2010
  No notice
• Disease-associated XMRV sequences are consistent with laboratory contamination · 2010
  No notice
• Plasma cytokines in women with chronic fatigue syndrome · 2009
  No notice
• Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients · 2009
  No notice
• Rapid Identification of Known and New RNA Viruses from Animal Tissues · 2008
  No notice
• The discovery of endogenous retroviruses · 2006
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.